Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Contributing writer

Kelsey Flood, MD
Harvard Medical School
Boston, United States

Kelsey Flood, MD is a clinical and research fellow in dermatology at Beth Israel Deaconess Medical Center and Harvard Medical School.

Last Updated: Apr 17, 2019

Kevin T. Savage, BA
Drexel University College of Medicine
Philadelphia, United States

Kevin T. Savage, BA is a rising fourth year medical student at Drexel University College of Medicine. He is currently completing a predoctoral research fellowship with Dr. Alexa B. Kimball in the Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS) in the Department of Dermatology at Beth Israel Deaconess Medical Center.

Last Updated: Apr 16, 2019

Psoriasis News

6/24/2019 10:08:00 AM
6/11/2019 9:58:00 AM
6/5/2019 12:03:00 PM
Corticosteroid therapy is regarded as first-line therapy for treating mild psoriasis and recalcitrant lesions. Members of the IPC Topical Therapies Working Group reviewed available international topical corticosteroids guidelines in order to understand current information and to identify areas that would benefit from greater practical guidance for dermatologists.
4/29/2019 7:28:00 AM
More News

This website uses cookies. Please ensure your cookies are enabled. 
OK